Compare LTC Properties Inc (LTC) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LTC Properties Inc vs ResMed Inc. — how do they compare? LTC Properties Inc trades at $41.74 (market cap $2.15B), while ResMed Inc. trades at $194.27 (market cap $28.81B). The key difference: ResMed Inc. is far larger — about 13.4× LTC Properties Inc's market cap, and LTC Properties Inc pays the higher dividend (5.44%). Which is the better fit depends on your goals.
| LTC | RMD | |
|---|---|---|
Market Cap | $2.15B | $28.81B |
Sector | Real Estate | Health |
52-Week High | $41.92 | $293.73 |
52-Week Low | $33.98 | $182.82 |
Enterprise Value | $2.99B | $27.99B |
Dividend Yield | 5.44% | 1.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LTC Properties (LTC) trades at $42.81, up 2.54% today, with a bullish technical signal supported by moving averages. The REIT shows strong fundamentals with a 67.32% gross margin and 39.09% net income margin, though recent earnings missed estimates. Recent acquisitions, including a $73M SHOP portfolio expansion, signal growth in the seniors housing sector. Analyst consensus is mixed, with 27% buy ratings but 59% hold, reflecting cautious optimism amid execution risks.
Outlook: LTC benefits from aging demographics and strategic acquisitions, but faces risks from debt levels and earnings volatility. The stock offers a steady dividend, yet investors should weigh high valuation multiples against growth execution. Near-term performance hinges on Q2 2026 earnings due August 5, 2026.
ResMed (RMD) trades at $195.8, down 1.6% on the day, with a bearish technical signal but strong fundamentals. Recent quarterly earnings have consistently beaten estimates, with Q1 2026 EPS of $2.86 exceeding the $2.80 forecast. The company sold its MatrixCare business for $490 million in July 2026 to sharpen focus on connected care, signaling strategic refinement. Revenue growth remains robust, climbing to $5.15 billion in 2025, with net income margins expanding to 27.44%.
The outlook is supported by solid earnings momentum and a consensus price target of $245.88, implying 25.6% upside. Risks include competitive pressures in medical equipment and reliance on sleep apnea market growth. Analyst sentiment is mixed with 40% buy ratings, but institutional selling by Baader Bank in Q1 2026 warrants monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
